Amicus Therapeutics (0HF9.LSE) Q4 2023 Earnings

28FebConfirmed
Q4 2023
-0.11
-0.09
-0.08
-0.06

Details

Expected EPS
-0.05782
Actual EPS
-0.11
Surprise EPS
-0.05
Surprise Percent
+90.25%

Description

Amicus Therapeutics (0HF9.LSE) has reported earnings of -0.11 per share for Q4 2023.

0 Comments

Share your thoughts